YK-11

pharmacological · endocrine · digestive · Oral

YK-11. Steroidal AR partial agonist + putative myostatin pathway inhibitor (follistatin upregulation). Banned by WADA. Hepatotoxicity signal at… Oral half-life 6 h.

Steroidal AR partial agonist + putative myostatin pathway inhibitor (follistatin upregulation). Banned by WADA. Hepatotoxicity signal at high doses; testosterone suppression similar to other SARMs at multi-week cycles.